- 24/12/2010 - Options
- 23/12/2010 - Biotron Limited Security Trading Policy
- 26/11/2010 - Results of Annual General Meeting
- 25/11/2010 - International Study Supports Biotron's HIV Drug Approach
- 11/11/2010 - Presentation to Investors
- 27/10/2010 - Annual Report for year ended 30 June 2010 and Notice of Annual General Meeting
- 27/10/2010 - Appendix 4C - Quarterly Report 30 September 2010
- 20/10/2010 - Presentation to Investors
- 14/10/2010 - Shareholder Update - October edition of BITNews
- 1/10/2010 - Phase II HCV Clinical Trial Commenced
- 31/08/2010 - Year End Accounts and Preliminary Final Report for year ended 30 June 2010
- 11/08/2010 - Appendix 4C - Quarterly Report 30 June 2010
- 23/07/2010 - Presentation at International AIDS Conference
- 30/06/2010 - Shareholder Update - June edition of BITNews
- 28/05/2010 - Issue of Shares
- 19/05/2010 - Change of Director's Interest Notice
- 30/04/2010 - Appointment of a Director
- 22/04/2010 - Appendix 4C - Quarterly Report 31 March 2010
- 1/04/2010 - Director Resignation
- 19/03/2010 - Shareholder Update and Piggy Back Options Opportunity
- 18/03/2010 - Biotron HCV Drug: International Partner to Progress Trial
- 26/02/2010 - Appendix 4D - Half Year Report 31 December 2009
- 5/02/2010 - Allotment and Distribution of New Options
- 27/01/2010 - Appendix 4C - Quarterly Report 31 December 2009
- 22/01/2010 - Change of Director's Interest Notice
- 15/01/2010 - Entitlement Issue 23% Oversubscribed
 |
 |
 |
 |
Latest share price
ASX:BIT
ASX:BIT